Rhinovirus

23 registered clinical trials studyying Rhinovirus — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study NCT07342582	University of Wisconsin, Madison	—
Recruiting	A Study of APL-10456-Vaccine NCT07399132	Apollo Therapeutics Ltd	EARLY_Phase 1
Recruiting	Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910	Institut Pasteur du Cambodge	—
Not Yet Recruiting	Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Se NCT07217639	Aptitude Medical Systems	N/A
Withdrawn	Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection NCT03508479	University of North Carolina, Chapel Hill	Phase 1
Completed	RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection NCT06149494	Altesa Biosciences, Inc.	Phase 2
Unknown	Impact of the Covid-19 on RSV Epidemic in the Metropolis of Lyon NCT05348655	Hospices Civils de Lyon	—
Unknown	Impact of Covid-19 on Rhinovirus Epidemic NCT05348707	Hospices Civils de Lyon	—
Unknown	Impact of the Covid-19 on RSV NCT05348616	Hospices Civils de Lyon	—
Completed	First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers. NCT05016687	Curovir AB	Phase 1
Completed	Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics NCT04670627	University of North Carolina, Chapel Hill	—
Terminated	Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus NCT04489381	Romark Laboratories L.C.	Phase 3
Completed	Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection NCT03605862	Romark Laboratories L.C.	Phase 3
Completed	Specific Respiratory Infections as Triggers of Acute Medical Events NCT02984280	University College, London	—
Completed	'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery' NCT02438293	Leiden University	—
Completed	Effect of OC459 on the Response to Rhinovirus Challenge in Asthma NCT02660489	Imperial College London	Phase 2
Completed	Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge NCT02522832	Hvivo	N/A
Completed	Collection and Testing of Respiratory Samples NCT01302418	QIAGEN Gaithersburg, Inc	—
Completed	The Respiratory Protection Effectiveness Clinical Trial NCT01249625	Johns Hopkins University	N/A
Completed	A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections NCT01158560	St. Joseph's Healthcare Hamilton	Phase 3
Completed	A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection NCT01175226	Biota Scientific Management Pty Ltd	Phase 2
Completed	Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposu NCT00394914	Merck Sharp & Dohme LLC	Phase 2
Withdrawn	A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Inf NCT03024177	Vaxart	Phase 2